New device aims to break vaping addiction without drugs
NCT ID NCT07322432
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests the VapeAway system, a drug-free program that uses special filters to slowly lower nicotine intake, a sensory tool called the Fix Bar, and digital support to help people stop vaping. About 70 motivated adults who vape daily will use the system for 42 days. Researchers want to see if at least 25% can stay vape-free for 30 days after the program, compared to the usual 7% who quit on their own.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- VapeAway filter system (device with nicotine tapering filters, Fix Bar behavioral tool, and digital support)
- What this could lead to
- If successful, this could provide a new, drug-free option to help people quit vaping, potentially improving health outcomes for nicotine addiction.
- What could go wrong
- This is a small, early-phase trial with only 70 participants and no placebo group. Results may not apply to everyone, and the program requires strict adherence to the 42-day protocol.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADDICTION NICOTINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Prime Infusion
RECRUITINGNew York, New York, 10128, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.